Quest Laboratories results, quarter to Mar 2026
NSE: QUESTLABPharmaceuticals & Biotechnology
Quest Laboratories Limited · Face value ₹10 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed May 2024 · Issue price ₹97
Last close ₹84.90up ₹2.95 (3.60%)
Share price at the NSE close on 28 Oct 2026. Previous close ₹81.95.
28 Oct: open ₹84.90, high ₹84.90, low ₹84.90
52-week range of traded prices to 28 Oct 2026
₹68.60Low, 21 Sep 2026₹152.60High, 30 Apr 2026
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. Market capitalisation: how it is worked out
- ₹139 Cr
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- No recent results
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- No recent results
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 1,200100.0% delivered
Quest Laboratories filed its results for the quarter to Mar 2026, standalone: the listed company alone, without its subsidiaries.
Results for the quarter to Mar 2026
- RevenueRevenue from operations. Money earned from selling the company's goods and services in the period. Revenue from operations in the glossary
- ₹32 Cr+5.9% on the quarter beforeChange on a year ago and on the quarter before. The change against the same quarter a year before: (this quarter's figure less that quarter's) divided by that quarter's, times 100. The change on the quarter before is the same sum against the quarter just before, taken as this quarter's results restate it where the company restated it: this quarter's year to date less this quarter. Left out where either figure is a loss, where the restatement covers two or more earlier quarters without saying which, or across a change of basis named under the table, on the lines it affects.
- Operating profitOperating profit before depreciation (EBITDA). Revenue less operating expenses: what the business earns from its operations before depreciation, interest and tax. Operating profit before depreciation (EBITDA) in the glossary
- ₹4.13 Cr−40.2% on the quarter before
- Net profitNet profit. What is left of revenue and other income after every cost, interest and tax. Net profit in the glossary
- ₹2.87 Cr−28.7% on the quarter before
- Operating marginOperating margin. Operating profit before depreciation as a percentage of revenue: how much of each rupee of sales is left after running costs. Operating margin in the glossary
- 12.8%
- Net marginNet margin. Net profit as a percentage of revenue: how much of each rupee of sales is left after every cost, interest and tax. Net margin in the glossary
- 8.9%
From revenue to net profit, ₹ crore
- Revenue32
- Materials and goods−27
- Employee costs−1.5
- Other expenses−0.1
- Operating profit4.1
- Depreciation−0.2
- Other income−1.3
- Finance costs−0.2
- Profit before tax2.5
- Tax+0.4
- Net profit2.9
Quest Laboratories results by quarter
Standalone: the listed company alone, without its subsidiaries. Latest quarter to Mar 2026. Results for the quarter to Jun 2026 were due by 14 Aug 2026, 45 days after it ends. Every company's dates are on the results calendar.Results filings and date
Revenue and net profit by quarter, ₹ crore
- Revenue
- Net profit
Peak revenue ₹32 Cr, quarter to Mar 2026; lowest ₹23 Cr, quarter to Jun 2025
Operating and net margin by quarter, per cent
- Operating margin
- Net margin
| ₹ crore | Jun 2025Q1 | Sep 2025worked out | Dec 2025Q3Filed 13 Feb | Mar 2026worked out |
|---|---|---|---|---|
| Revenue from operations | 23.2 | 25.6what Revenue from operations, Sep 2025, includes. Not filed on its own: worked out as the six months to Sep 2025 the company filed, less the three months to Jun 2025. | 30.6 | 32.4what Revenue from operations, Mar 2026, includes. Not filed on its own: worked out as the six months to Mar 2026 the company filed, less the three months to Dec 2025. |
| Operating expenses. What the business spent to run itself in the period, materials, staff and other costs, before depreciation, interest and tax. Operating expenses in the glossary | 19.4 | 22.2 | 23.7 | 28.3 |
| Materials and goods boughtCost of materials and goods. Raw materials used and goods bought for resale in the period, adjusted for the change in stock held. Cost of materials and goods in the glossary | 17.8 | 20.7 | 21.1 | 26.8 |
| Employee costsEmployee costs. Salaries, wages, bonuses and other benefits paid to staff in the period. Employee costs in the glossary | 1.0 | 1.1 | 1.2 | 1.5 |
| Other expensesOther expenses. Every operating cost besides materials and staff: power, rent, freight, repairs, marketing and the like. Other expenses in the glossary | 0.5 | 0.5 | 1.4 | 0.1 |
| Operating profit before depreciation | 3.8 | 3.4 | 6.9 | 4.1 |
| Operating margin | 16.4% | 13.2% | 22.6% | 12.8% |
| Depreciation and amortisationDepreciation and amortisation. The part of the cost of plant, buildings and other long-lived assets charged against each year they are used. Depreciation and amortisation in the glossary | 0.2 | 0.2 | 0.2 | 0.2 |
| Other incomeOther income. Income from outside the main business, such as interest on deposits, dividends received and gains on investments. Other income in the glossary | 1.9 | 1.4 | 0.6 | −1.3 |
| Finance costsFinance costs. Interest and the other costs of borrowing in the period. Finance costs in the glossary | 0.6 | 0.6 | 0.5 | 0.2 |
| One-off itemsExceptional items. Gains or losses the company reports separately because they are not expected to recur, such as selling a business or writing down an asset. Exceptional items in the glossary | 0.0 | 0.0 | 0.0 | 0.0 |
| Profit before tax | 4.8 | 4.0 | 6.8 | 2.5 |
| 0.7 | – | 2.8 | −0.4 | |
| Tax rateEffective tax rate. Tax charged as a percentage of profit before tax. Effective tax rate in the glossary | 14.9% | – | 40.8% | −16.6% |
| Net profit | 4.1 | 4.0 | 4.0 | 2.9 |
| Net margin | 17.7% | 15.7% | 13.2% | 8.9% |
| Earnings per shareEarnings per share. Profit belonging to shareholders divided by the number of shares, restated for later splits and bonuses so they do not break the line. Earnings per share in the glossary | ₹2.50 | – | ₹2.46 | – |
Earnings per share in rupees, restated for later splits and bonuses.
Quest Laboratories results by half year
Standalone: the listed company alone, without its subsidiaries. The half years to Sep 2024 in the same span that the quarters on record do not fully cover.
| ₹ crore | Sep 2023 | Mar 2024 | Sep 2024 |
|---|---|---|---|
| Revenue from operations | 41.0 | 41.5 | 42.6 |
| 31.6 | 35.4 | 31.3 | |
| Materials and goods bought | 25.8 | 26.4 | 23.9 |
| Employee costs | 2.3 | 2.0 | 1.9 |
| Other expenses | 3.5 | 7.0 | 5.5 |
| Operating profit before depreciation | 9.4 | 6.2 | 11.4 |
| Operating margin | 22.9% | 14.8% | 26.7% |
| Depreciation and amortisation | 0.3 | 0.3 | 0.3 |
| Other income | 0.1 | 0.2 | 0.8 |
| Finance costs | 0.3 | 0.4 | 0.5 |
| One-off items | 0.0 | 0.0 | 0.0 |
| Profit before tax | 8.8 | 5.6 | 11.4 |
| Tax | 2.5 | 1.9 | 3.4 |
| Tax rate | 28.3% | 33.0% | 29.7% |
| Net profit | 6.3 | 3.8 | 8.0 |
| Net margin | 15.4% | 9.1% | 18.8% |
Earnings per share in rupees, restated for later splits and bonuses.